Design And Development of Co-Processed Chitin-Lactose Monohydrate as An Excipient for Oral Dispersible Tablets

This study describes the preparation, characterization and performance of a novel excipient for use in oral-dispersible tablets (ODT). The excipient (Cop–CLM) consists of chitin and lactose monohydrate. Specific benefits of co-processed excipients include improved flow, compressibility, disintegrating effect, and masking undesirable properties of individual excipients. The excipient with optimal physicochemical properties was obtained at a chitin: lactose monohydrate ratio of 1:2 (w/w) and produced by direct mixing. Physical properties of Co-processed chitin-lactose monohydrate (1:2 w/w) powder showed good flowability and compressibility. Differential scanning calorimetry (DSC), Fourier Transform-Infrared (FT-IR) techniques were used to characterize Cop-CLM, in addition to characterization of a powder and ODT dosage form. Heckel plot of Cop-CLM showed higher value of K (0.647) than lactose monohydrate (0.355) and chitin (0.255), which indicates more plastic material. Ondansetron ODTs were prepared, using Cop-CLM displayed excellent physiochemical properties like fast disintegration, wetting time and exceptional binding in comparison with commercially available ODT. This study concludes that Cop-CLM results in a unique multifunctional base which can successfully be used in the formulation of oral-dispersible and fast immediate release tablets.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-04
DOI
https://doi.org/10.5281/zenodo.14035182
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design And Development of Co-Processed Chitin-Lactose Monohydrate as An Excipient for Oral Dispersible Tablets

Zenodo (CERN European Organization for Nuclear Research)
Treatment of Major Depression
article

Design And Development of Co-Processed Chitin-Lactose Monohydrate as An Excipient for Oral Dispersible Tablets

article en

Abstract

This study describes the preparation, characterization and performance of a novel excipient for use in oral-dispersible tablets (ODT). The excipient (Cop–CLM) consists of chitin and lactose monohydrate. Specific benefits of co-processed excipients include improved flow, compressibility, disintegrating effect, and masking undesirable properties of individual excipients. The excipient with optimal physicochemical properties was obtained at a chitin: lactose monohydrate ratio of 1:2 (w/w) and produced by direct mixing. Physical properties of Co-processed chitin-lactose monohydrate (1:2 w/w) powder showed good flowability and compressibility. Differential scanning calorimetry (DSC), Fourier Transform-Infrared (FT-IR) techniques were used to characterize Cop-CLM, in addition to characterization of a powder and ODT dosage form. Heckel plot of Cop-CLM showed higher value of K (0.647) than lactose monohydrate (0.355) and chitin (0.255), which indicates more plastic material. Ondansetron ODTs were prepared, using Cop-CLM displayed excellent physiochemical properties like fast disintegration, wetting time and exceptional binding in comparison with commercially available ODT. This study concludes that Cop-CLM results in a unique multifunctional base which can successfully be used in the formulation of oral-dispersible and fast immediate release tablets.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 50%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Design And Development of Co-Processed Chitin-Lactose Monohydrate as An Excipient for Oral Dispersible Tablets · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS